Roche Pharmaceuticals (Switzerland) Hero Image

Roche

Roche, a global healthcare company, invested CHF 13.2 billion in R&D in 2023. Its Basel research center houses over 1,800 scientists from nearly 60 countries, and its Zurich facility employs about 185 research scientists. Roche's R&D spans 17 countries across four continents, focusing on oncology, personalized medicine, genomic sequencing, diagnostics, and digital health solutions. The company integrates diagnostics and pharmaceuticals and held 336 active patent families in 2023. Roche leads Swiss companies in patent applications and ranks 24th globally across all industries.

Founded 1896
Visit Website

Overview

Featured Content

Roche Innovation Center Basel

The Roche Innovation Center Basel is the company's largest research center, housing over 1,800 scientists from nearly 60 countries. It is a hub for Roche's research efforts in oncology, personalized medicine, genomic sequencing, and diagnostics.

Research Areas

OncologyPersonalized MedicineGenomic SequencingDiagnosticsPharmaceuticalsBiotechnologyBlood Glucose MonitoringNeuroscienceRare DiseasesCardiovascular and Metabolic DiseasesImmunologyInfectious DiseasesOphthalmologyDigital Health Solutions

Publications per Year

Data for 2024 is incomplete and represents only part of the year.

Patents per Year

Data for 2024 is incomplete and represents only part of the year. Updated with BigQuery patent data pulled on October 26, 2024.

Location on Map

Related Content

Roche, Foundation Medicine Team Up for Cancer Treatment Research

Roche, Foundation Medicine Team Up for Cancer Treatment Research

Read More

Explore More Labs